Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Jennifer Diamond

Concepts (280)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Triple Negative Breast Neoplasms
15
2023
164
7.200
 Why?
Breast Neoplasms
23
2023
1965
4.870
 Why?
Immunoconjugates
7
2023
89
2.860
 Why?
Antineoplastic Agents
23
2023
1974
2.820
 Why?
Antineoplastic Combined Chemotherapy Protocols
19
2023
1390
2.800
 Why?
Pyrimidines
9
2021
382
2.680
 Why?
Receptor, ErbB-2
11
2023
320
2.120
 Why?
Protein Kinase Inhibitors
10
2022
811
1.900
 Why?
Piperazines
4
2020
316
1.840
 Why?
Neoplasms
14
2022
2179
1.810
 Why?
Paclitaxel
6
2022
195
1.770
 Why?
Camptothecin
9
2023
100
1.750
 Why?
Pyrazoles
6
2021
363
1.540
 Why?
Quinoxalines
2
2020
62
1.430
 Why?
Ovarian Neoplasms
4
2020
420
1.370
 Why?
Azepines
3
2020
74
1.370
 Why?
Antibodies, Monoclonal, Humanized
9
2021
667
1.310
 Why?
Cyclin-Dependent Kinase 4
2
2018
32
1.220
 Why?
Cyclin-Dependent Kinase 6
2
2018
37
1.200
 Why?
Histone Deacetylase Inhibitors
3
2023
200
1.100
 Why?
Neutropenia
4
2022
133
0.970
 Why?
Gene Expression Regulation, Neoplastic
5
2020
1167
0.880
 Why?
Xenograft Model Antitumor Assays
11
2021
740
0.840
 Why?
beta Catenin
2
2020
219
0.820
 Why?
Breast Neoplasms, Male
2
2018
31
0.800
 Why?
Female
48
2023
61565
0.790
 Why?
Lymphocytes, Tumor-Infiltrating
2
2020
112
0.770
 Why?
Chemotherapy, Adjuvant
4
2023
360
0.760
 Why?
Maximum Tolerated Dose
9
2022
185
0.750
 Why?
Cancer Care Facilities
1
2020
35
0.750
 Why?
Benzoxazoles
1
2020
16
0.750
 Why?
Receptors, Estrogen
3
2021
387
0.750
 Why?
Carcinoma, Lobular
2
2018
56
0.730
 Why?
eIF-2 Kinase
1
2019
26
0.710
 Why?
Tumor Microenvironment
3
2020
454
0.680
 Why?
Anthracyclines
3
2023
41
0.670
 Why?
Humans
60
2023
118974
0.660
 Why?
Taxoids
3
2023
98
0.650
 Why?
Drug Resistance, Neoplasm
4
2020
671
0.640
 Why?
Aged
22
2023
19657
0.640
 Why?
Wnt Signaling Pathway
1
2019
150
0.630
 Why?
Aurora Kinase A
4
2020
52
0.620
 Why?
Carcinoma, Ductal, Breast
1
2018
91
0.610
 Why?
Trastuzumab
4
2023
92
0.610
 Why?
Pyrazines
2
2018
72
0.600
 Why?
Myocardial Infarction
1
2023
968
0.570
 Why?
Colonic Neoplasms
1
2018
224
0.560
 Why?
Pyridines
2
2018
440
0.550
 Why?
Neoadjuvant Therapy
1
2018
333
0.550
 Why?
Nuclear Proteins
2
2023
597
0.540
 Why?
Angiopoietin-1
1
2015
10
0.530
 Why?
Angiopoietin-2
1
2015
13
0.530
 Why?
Tumor Suppressor Protein p53
3
2016
455
0.500
 Why?
Medicare
4
2023
663
0.500
 Why?
Cell Line, Tumor
9
2022
2851
0.490
 Why?
Colorectal Neoplasms
5
2022
628
0.490
 Why?
Uterine Cervical Neoplasms
1
2017
216
0.490
 Why?
Middle Aged
23
2021
27617
0.480
 Why?
Tumor Suppressor Proteins
1
2015
289
0.440
 Why?
Proto-Oncogene Proteins c-met
1
2013
69
0.440
 Why?
Cell Proliferation
8
2020
2275
0.440
 Why?
Adult
23
2022
31512
0.440
 Why?
Dose-Response Relationship, Drug
6
2022
1945
0.440
 Why?
Antineoplastic Agents, Immunological
3
2019
156
0.430
 Why?
Treatment Outcome
12
2022
9342
0.430
 Why?
Point Mutation
1
2013
228
0.420
 Why?
Recombinant Fusion Proteins
1
2015
653
0.420
 Why?
Triazoles
1
2013
134
0.420
 Why?
Angiogenesis Inhibitors
3
2018
219
0.400
 Why?
Mitochondria
1
2017
786
0.390
 Why?
Mice, Nude
6
2020
663
0.390
 Why?
Carcinoma, Renal Cell
1
2013
174
0.390
 Why?
Neoplasm Recurrence, Local
4
2021
900
0.380
 Why?
Clinical Trials, Phase I as Topic
2
2020
47
0.380
 Why?
Heart Failure
1
2023
1969
0.380
 Why?
Histones
3
2023
552
0.370
 Why?
Neoplasm Metastasis
4
2020
544
0.370
 Why?
Genes, BRCA2
1
2009
25
0.360
 Why?
Biomarkers, Tumor
2
2014
1059
0.360
 Why?
Genes, BRCA1
1
2009
31
0.360
 Why?
Aged, 80 and over
8
2020
6561
0.350
 Why?
Molecular Targeted Therapy
3
2019
356
0.350
 Why?
BRCA2 Protein
1
2009
44
0.350
 Why?
Neoplasm Staging
5
2021
1223
0.340
 Why?
Pregnancy Complications, Neoplastic
1
2009
51
0.340
 Why?
Thrombophilia
1
2009
68
0.340
 Why?
Kidney Neoplasms
1
2013
334
0.340
 Why?
Quinolines
2
2021
128
0.330
 Why?
Aromatase Inhibitors
2
2018
52
0.330
 Why?
DNA-Binding Proteins
1
2015
1346
0.310
 Why?
Receptors, Progesterone
2
2021
325
0.310
 Why?
Antibodies, Monoclonal
3
2020
1284
0.300
 Why?
Mice
9
2021
15520
0.300
 Why?
Apoptosis
6
2022
2484
0.290
 Why?
Models, Biological
1
2014
1715
0.280
 Why?
Liver Neoplasms
1
2009
527
0.260
 Why?
Cyclophosphamide
2
2018
222
0.240
 Why?
Lung Neoplasms
1
2017
2220
0.240
 Why?
Disease Models, Animal
3
2021
3730
0.240
 Why?
United States
5
2023
12555
0.240
 Why?
Radiosurgery
2
2019
318
0.230
 Why?
Doxorubicin
2
2018
302
0.230
 Why?
Animals
11
2021
33381
0.220
 Why?
Cyclin-Dependent Kinase 9
1
2022
9
0.210
 Why?
Histone Deacetylase 1
1
2022
16
0.210
 Why?
Disease Progression
4
2019
2490
0.210
 Why?
Biopsy
2
2018
1079
0.210
 Why?
Aurora Kinases
2
2012
28
0.210
 Why?
G2 Phase Cell Cycle Checkpoints
3
2022
40
0.210
 Why?
Administration, Oral
3
2022
756
0.210
 Why?
Fluorouracil
1
2022
151
0.210
 Why?
Topoisomerase I Inhibitors
2
2022
16
0.210
 Why?
Arrhythmias, Cardiac
1
2023
277
0.200
 Why?
Acetylation
1
2022
217
0.200
 Why?
Male
14
2021
57801
0.200
 Why?
Biliary Tract Neoplasms
1
2021
20
0.200
 Why?
Androstadienes
1
2021
94
0.190
 Why?
Fatigue
2
2022
297
0.190
 Why?
Carboplatin
1
2021
142
0.190
 Why?
Immunotherapy
2
2023
493
0.190
 Why?
Heterografts
1
2021
130
0.190
 Why?
Diarrhea
2
2019
181
0.190
 Why?
Hospitals, University
1
2021
172
0.190
 Why?
Necrosis
2
2019
230
0.190
 Why?
Drug Administration Schedule
3
2017
736
0.190
 Why?
Histone Deacetylases
1
2022
198
0.190
 Why?
Clinical Trials as Topic
3
2016
969
0.180
 Why?
Mechanistic Target of Rapamycin Complex 2
1
2020
59
0.180
 Why?
Benzodiazepines
1
2021
122
0.180
 Why?
Myeloid Cell Leukemia Sequence 1 Protein
1
2019
21
0.180
 Why?
Mechanistic Target of Rapamycin Complex 1
1
2020
104
0.180
 Why?
Immune System
1
2021
181
0.180
 Why?
Kaplan-Meier Estimate
1
2021
842
0.170
 Why?
Tumor Cells, Cultured
1
2020
874
0.170
 Why?
Aquaporin 4
1
2019
87
0.170
 Why?
Albumins
1
2019
100
0.160
 Why?
Maintenance Chemotherapy
1
2018
23
0.160
 Why?
Antibodies, Bispecific
1
2018
33
0.160
 Why?
Nausea
1
2018
107
0.160
 Why?
Aminopyridines
1
2018
85
0.160
 Why?
Vascular Endothelial Growth Factor A
2
2018
527
0.160
 Why?
Breast
1
2018
140
0.160
 Why?
Mastectomy
1
2018
124
0.160
 Why?
Mice, Inbred BALB C
1
2020
1206
0.160
 Why?
Drug Therapy, Combination
1
2020
965
0.150
 Why?
Radiotherapy, Adjuvant
1
2018
189
0.150
 Why?
Benzimidazoles
1
2018
140
0.150
 Why?
Purines
1
2018
161
0.150
 Why?
Topotecan
1
2017
13
0.150
 Why?
Isoflavones
1
2017
24
0.150
 Why?
Imidazoles
1
2018
232
0.150
 Why?
Calcium-Binding Proteins
1
2018
217
0.150
 Why?
Programmed Cell Death 1 Receptor
1
2019
197
0.150
 Why?
Carbolines
1
2017
29
0.150
 Why?
Heterocyclic Compounds, 4 or More Rings
1
2017
16
0.150
 Why?
Nanoparticles
1
2021
325
0.150
 Why?
Survival Analysis
1
2020
1267
0.150
 Why?
Inhibitory Concentration 50
2
2016
81
0.150
 Why?
Neoplasms, Radiation-Induced
1
2016
66
0.140
 Why?
Insulin-Like Growth Factor I
1
2018
287
0.140
 Why?
Cell Survival
1
2019
1047
0.140
 Why?
Hypertension
2
2018
1203
0.140
 Why?
GPI-Linked Proteins
1
2016
56
0.140
 Why?
Neoplasms, Second Primary
1
2016
93
0.130
 Why?
Adaptor Proteins, Signal Transducing
1
2018
394
0.130
 Why?
Tumor Protein p73
1
2015
15
0.130
 Why?
Antibodies, Neoplasm
1
2015
30
0.130
 Why?
Retrospective Studies
3
2021
12978
0.130
 Why?
Risk Reduction Behavior
1
2016
199
0.130
 Why?
Hodgkin Disease
1
2016
119
0.130
 Why?
Phosphorylation
1
2019
1633
0.130
 Why?
Maytansine
1
2014
13
0.130
 Why?
Demography
1
2015
274
0.120
 Why?
Brain Edema
1
2014
61
0.120
 Why?
Randomized Controlled Trials as Topic
1
2019
1244
0.120
 Why?
Survival Rate
2
2019
1720
0.120
 Why?
Drug Interactions
1
2015
352
0.120
 Why?
Protein Kinases
1
2015
310
0.120
 Why?
Sulfones
1
2014
98
0.110
 Why?
Threonine
1
2013
45
0.110
 Why?
Analgesics, Opioid
1
2021
794
0.110
 Why?
Glycine
1
2014
162
0.110
 Why?
Tumor Stem Cell Assay
1
2012
35
0.110
 Why?
Drug Evaluation, Preclinical
1
2013
180
0.110
 Why?
Time Factors
2
2020
6412
0.110
 Why?
Methionine
1
2013
145
0.110
 Why?
Drug Design
1
2013
160
0.110
 Why?
Heterozygote
1
2013
262
0.110
 Why?
Disease-Free Survival
1
2014
649
0.110
 Why?
In Situ Hybridization, Fluorescence
1
2013
310
0.100
 Why?
Treatment Failure
1
2013
341
0.100
 Why?
Neovascularization, Pathologic
1
2013
287
0.100
 Why?
Computational Biology
1
2015
588
0.100
 Why?
Cellular Senescence
1
2012
151
0.100
 Why?
Cell Transformation, Neoplastic
1
2013
317
0.100
 Why?
Risk Assessment
1
2020
3057
0.100
 Why?
Carcinoma in Situ
1
2011
45
0.100
 Why?
Cluster Analysis
1
2012
481
0.100
 Why?
Receptor Protein-Tyrosine Kinases
1
2013
229
0.100
 Why?
Colorado
1
2020
4196
0.100
 Why?
Vascular Endothelial Growth Factor Receptor-2
1
2010
86
0.090
 Why?
Mutation
2
2012
3457
0.090
 Why?
Brain Neoplasms
2
2019
1022
0.090
 Why?
Sequence Analysis, DNA
1
2013
755
0.090
 Why?
Tumor Burden
1
2010
274
0.090
 Why?
Pregnancy Trimester, Second
1
2009
70
0.090
 Why?
Keratinocytes
1
2010
227
0.090
 Why?
Mastectomy, Segmental
1
2009
91
0.090
 Why?
Pregnancy Trimester, First
1
2009
126
0.080
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2009
76
0.080
 Why?
Apoptosis Regulatory Proteins
1
2009
190
0.080
 Why?
Lymph Node Excision
1
2009
158
0.080
 Why?
Infusions, Intravenous
2
2019
380
0.070
 Why?
Cell Adhesion Molecules
2
2019
180
0.070
 Why?
Risk Factors
1
2020
9000
0.070
 Why?
Risk
1
2009
853
0.070
 Why?
Prognosis
2
2018
3443
0.070
 Why?
Antigens, Neoplasm
2
2019
228
0.070
 Why?
CD8-Positive T-Lymphocytes
2
2023
702
0.070
 Why?
Gene Expression Profiling
1
2012
1597
0.070
 Why?
Cell Cycle Proteins
2
2023
565
0.070
 Why?
Cell Cycle
2
2018
550
0.060
 Why?
Combined Modality Therapy
2
2019
1166
0.060
 Why?
Mesylates
1
2022
8
0.060
 Why?
Signal Transduction
2
2014
4709
0.060
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2022
62
0.050
 Why?
Clinical Protocols
1
2023
238
0.050
 Why?
Chimerism
1
2021
28
0.050
 Why?
Lymphoid Tissue
1
2021
65
0.050
 Why?
Lymphocyte Subsets
1
2021
76
0.050
 Why?
Liver
1
2009
1816
0.050
 Why?
Mice, SCID
1
2021
333
0.050
 Why?
SEER Program
1
2021
205
0.050
 Why?
Hormones
1
2020
135
0.050
 Why?
Mice, Inbred NOD
1
2021
574
0.040
 Why?
M Phase Cell Cycle Checkpoints
1
2018
23
0.040
 Why?
Infant, Newborn
1
2009
5255
0.040
 Why?
Tissue Distribution
1
2018
334
0.040
 Why?
Anemia
1
2019
146
0.040
 Why?
Pregnancy
1
2009
5691
0.040
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2016
109
0.030
 Why?
Retreatment
1
2016
71
0.030
 Why?
Cetuximab
1
2016
99
0.030
 Why?
Neoplasm Transplantation
1
2016
245
0.030
 Why?
Platinum
1
2016
38
0.030
 Why?
Drug Screening Assays, Antitumor
1
2016
189
0.030
 Why?
Hematopoietic Stem Cell Transplantation
1
2021
540
0.030
 Why?
Proto-Oncogene Proteins p21(ras)
1
2016
237
0.030
 Why?
History, Ancient
1
2015
58
0.030
 Why?
Transcription Factors
1
2023
1570
0.030
 Why?
Biomarkers
2
2016
3588
0.030
 Why?
Mice, Knockout
1
2021
2680
0.030
 Why?
DNA Damage
1
2017
357
0.030
 Why?
Databases, Genetic
1
2015
253
0.030
 Why?
Opioid-Related Disorders
1
2021
417
0.030
 Why?
Phenotype
1
2021
3003
0.030
 Why?
Drug Combinations
1
2013
291
0.030
 Why?
Intracellular Signaling Peptides and Proteins
1
2015
404
0.030
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2015
245
0.030
 Why?
Immunohistochemistry
1
2016
1691
0.030
 Why?
Transcription, Genetic
1
2017
1323
0.020
 Why?
Cohort Studies
1
2021
5116
0.020
 Why?
Biopsy, Needle
1
2011
190
0.020
 Why?
HT29 Cells
1
2010
37
0.020
 Why?
Proto-Oncogene Proteins
1
2014
618
0.020
 Why?
ErbB Receptors
1
2013
569
0.020
 Why?
Enzyme Inhibitors
1
2014
827
0.020
 Why?
Protein-Tyrosine Kinases
1
2013
407
0.020
 Why?
Ki-67 Antigen
1
2010
108
0.020
 Why?
Capillary Permeability
1
2010
140
0.020
 Why?
Patient Selection
1
2013
676
0.020
 Why?
Follow-Up Studies
1
2018
4596
0.020
 Why?
Patient Satisfaction
1
2013
610
0.020
 Why?
Membrane Proteins
1
2015
1055
0.020
 Why?
Positron-Emission Tomography
1
2010
298
0.020
 Why?
Algorithms
1
2015
1541
0.020
 Why?
Magnetic Resonance Imaging
1
2019
3174
0.020
 Why?
Tomography, X-Ray Computed
1
2016
2436
0.020
 Why?
Brain
1
2014
2490
0.010
 Why?
Young Adult
1
2014
10793
0.010
 Why?
Diamond's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (280) concept(s)
_
Co-Authors Expand Description
See all (62) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)